Agnes Bosch

950 total citations
45 papers, 568 citations indexed

About

Agnes Bosch is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Agnes Bosch has authored 45 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 18 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Agnes Bosch's work include Blood Pressure and Hypertension Studies (17 papers), Diabetes Treatment and Management (14 papers) and Cardiovascular Health and Disease Prevention (12 papers). Agnes Bosch is often cited by papers focused on Blood Pressure and Hypertension Studies (17 papers), Diabetes Treatment and Management (14 papers) and Cardiovascular Health and Disease Prevention (12 papers). Agnes Bosch collaborates with scholars based in Germany, Poland and Belarus. Agnes Bosch's co-authors include Roland E. Schmieder, Dennis Kannenkeril, Kristina Striepe, Christian Ott, Susanne Jung, Marina V. Karg, Michael Uder, Armin M. Nagel, Peter Linz and Joanna Haraźny and has published in prestigious journals such as Scientific Reports, Hypertension and Journal of Hypertension.

In The Last Decade

Agnes Bosch

40 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agnes Bosch Germany 13 295 218 150 124 106 45 568
Kristina Striepe Germany 10 362 1.2× 195 0.9× 154 1.0× 129 1.0× 81 0.8× 33 539
Marina V. Karg Germany 7 309 1.0× 145 0.7× 129 0.9× 111 0.9× 68 0.6× 17 422
Ling Ge United States 11 483 1.6× 190 0.9× 110 0.7× 192 1.5× 93 0.9× 24 798
K. Py�r�l� Finland 9 456 1.5× 300 1.4× 157 1.0× 115 0.9× 35 0.3× 13 774
Giuseppe Andronico Italy 17 295 1.0× 631 2.9× 124 0.8× 75 0.6× 96 0.9× 35 896
Tetsutaro Matayoshi Japan 12 104 0.4× 192 0.9× 49 0.3× 83 0.7× 68 0.6× 25 403
Ruggero Mangili Italy 13 495 1.7× 394 1.8× 114 0.8× 150 1.2× 105 1.0× 23 1.0k
Esben Stistrup Lauritzen Denmark 8 205 0.7× 130 0.6× 43 0.3× 43 0.3× 35 0.3× 17 542
R. E. Schmieder Germany 9 111 0.4× 403 1.8× 53 0.4× 50 0.4× 48 0.5× 16 639
Y Ohkubo Japan 4 529 1.8× 124 0.6× 107 0.7× 149 1.2× 20 0.2× 9 731

Countries citing papers authored by Agnes Bosch

Since Specialization
Citations

This map shows the geographic impact of Agnes Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnes Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnes Bosch more than expected).

Fields of papers citing papers by Agnes Bosch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnes Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnes Bosch. The network helps show where Agnes Bosch may publish in the future.

Co-authorship network of co-authors of Agnes Bosch

This figure shows the co-authorship network connecting the top 25 collaborators of Agnes Bosch. A scholar is included among the top collaborators of Agnes Bosch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnes Bosch. Agnes Bosch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kannenkeril, Dennis, Julie Kolwelter, Peter Linz, et al.. (2025). Short- and Mid-Term Effects of Empagliflozin on Sodium Balance and Fluid Regulation in Chronic Heart Failure. European Journal of Heart Failure. 27(12). 3134–3141.
2.
Kannenkeril, Dennis, Agnes Bosch, Julie Kolwelter, et al.. (2024). PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease. Clinical Research in Cardiology. 115(2). 220–231. 1 indexed citations
3.
Delles, Christian, Roland E. Schmieder, Rónán Daly, et al.. (2024). Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic Variants. Hypertension. 82(1). 118–125. 1 indexed citations
4.
Schmid, Axel, Christian Ott, Agnes Bosch, et al.. (2023). Blood pressure reduction after renal denervation in patients with or without chronic kidney disease. Clinical Kidney Journal. 17(1). sfad237–sfad237. 4 indexed citations
5.
Schmid, Axel, Dennis Kannenkeril, Peter Linz, et al.. (2023). Skin sodium content as a predictor of blood pressure response to renal denervation. Hypertension Research. 47(2). 361–371. 3 indexed citations
6.
Bosch, Agnes, Dennis Kannenkeril, Christian Ott, et al.. (2023). Relation between waist circumference and the renal hemodynamic in healthy individuals. Nutrition Metabolism and Cardiovascular Diseases. 34(3). 755–762. 2 indexed citations
7.
Bosch, Agnes, Marko Poglitsch, Dennis Kannenkeril, et al.. (2023). Angiotensin Pathways Under Therapy with Empagliflozin in Patients with Chronic Heart Failure. ESC Heart Failure. 10(3). 1635–1642. 5 indexed citations
8.
Ott, Christian, Dennis Kannenkeril, Kristina Striepe, et al.. (2023). Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis. Scientific Reports. 13(1). 8944–8944. 9 indexed citations
9.
Kolwelter, Julie, Dennis Kannenkeril, Peter Linz, et al.. (2022). The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial. Clinical Research in Cardiology. 112(1). 134–144. 18 indexed citations
10.
11.
Gessner, Arne, Agnes Bosch, Dennis Kannenkeril, et al.. (2022). Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers. Cardiovascular Diabetology. 21(1). 4–4. 9 indexed citations
12.
Bosch, Agnes, Dennis Kannenkeril, Kristina Striepe, et al.. (2022). Is Vascular Remodelling in Patients with Chronic Heart Failure Exaggerated?. ESC Heart Failure. 10(1). 245–254. 3 indexed citations
13.
Kannenkeril, Dennis, Agnes Bosch, Julie Kolwelter, et al.. (2021). Dependency of flow‐mediated vasodilatation from basal nitric oxide activity. Clinical Physiology and Functional Imaging. 41(4). 310–316. 8 indexed citations
14.
Kolwelter, Julie, Agnes Bosch, Susanne Jung, et al.. (2021). Effects of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function in Patients with Chronic Heart Failure. ESC Heart Failure. 8(6). 5327–5337. 22 indexed citations
15.
Ott, Christian, Susanne Jung, Dennis Kannenkeril, et al.. (2021). Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine. Cardiovascular Diabetology. 20(1). 178–178. 21 indexed citations
16.
Jung, Susanne, Agnes Bosch, Julie Kolwelter, et al.. (2021). Renal and Intraglomerular Haemodynamics in Chronic Heart Failure with Preserved and Reduced Ejection Fraction. ESC Heart Failure. 8(2). 1562–1570. 10 indexed citations
17.
Bosch, Agnes & Roland E. Schmieder. (2020). Novel approaches to management of hypertension. Current Opinion in Nephrology & Hypertension. 30(1). 54–62. 2 indexed citations
18.
Ott, Christian, Susanne Jung, Agnes Bosch, et al.. (2019). 4.6 Effects of Combined Therapy of Empagliflozin and Linagliptin Versus Metformin and Insulin Glargine on Blood Pressure and Vascular Function in Patients with Type 2 Diabetes. Artery Research. 25(S1). S35–S35. 1 indexed citations
19.
Bosch, Agnes, Johannes B. Scheppach, Joanna Haraźny, et al.. (2018). Retinal capillary and arteriolar changes in patients with chronic kidney disease. Microvascular Research. 118. 121–127. 19 indexed citations
20.
Bosch, Agnes, Joanna Haraźny, Iris Kistner, et al.. (2017). Retinal capillary rarefaction in patients with untreated mild-moderate hypertension. BMC Cardiovascular Disorders. 17(1). 300–300. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristina Striepe Breakdown of academic impact, for papers by Marina V. Karg Breakdown of academic impact, for papers by Ling Ge Breakdown of academic impact, for papers by K. Py�r�l� Breakdown of academic impact, for papers by Giuseppe Andronico Breakdown of academic impact, for papers by Tetsutaro Matayoshi Breakdown of academic impact, for papers by Ruggero Mangili Breakdown of academic impact, for papers by Esben Stistrup Lauritzen Breakdown of academic impact, for papers by R. E. Schmieder Breakdown of academic impact, for papers by Y Ohkubo
Rankless by CCL
2026